AMN Healthcare Services, Inc. (AMN)
NYSE: AMN · Real-Time Price · USD
20.83
-0.21 (-1.00%)
At close: Sep 9, 2025, 4:00 PM
20.83
0.00 (0.00%)
After-hours: Sep 9, 2025, 7:00 PM EDT
AMN Healthcare Services Market Cap
AMN Healthcare Services has a market cap or net worth of $798.29 million as of September 9, 2025. Its market cap has decreased by -58.86% in one year.
Market Cap
798.29M
Enterprise Value
1.71B
1-Year Change
-58.86%
Ranking
Category
Stock Price
$20.83
Market Cap Chart
Since November 13, 2001, AMN Healthcare Services's market cap has decreased from $881.10M to $798.29M, a decrease of -9.40%. That is a compound annual growth rate of -0.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 806.30M | -11.46% |
| Dec 31, 2024 | 910.70M | -67.82% |
| Dec 29, 2023 | 2.83B | -36.49% |
| Dec 30, 2022 | 4.46B | -22.95% |
| Dec 31, 2021 | 5.78B | 80.17% |
| Dec 31, 2020 | 3.21B | 10.28% |
| Dec 31, 2019 | 2.91B | 9.61% |
| Dec 31, 2018 | 2.66B | 12.87% |
| Dec 29, 2017 | 2.35B | 27.35% |
| Dec 30, 2016 | 1.85B | 24.76% |
| Dec 31, 2015 | 1.48B | 62.02% |
| Dec 31, 2014 | 914.00M | 35.15% |
| Dec 31, 2013 | 676.30M | 31.91% |
| Dec 31, 2012 | 512.70M | 186.10% |
| Dec 30, 2011 | 179.20M | -25.36% |
| Dec 31, 2010 | 240.10M | -18.78% |
| Dec 31, 2009 | 295.60M | 7.26% |
| Dec 31, 2008 | 275.60M | -52.55% |
| Dec 31, 2007 | 580.80M | -38.02% |
| Dec 29, 2006 | 937.10M | 64.66% |
| Dec 30, 2005 | 569.10M | 26.19% |
| Dec 31, 2004 | 451.00M | -6.53% |
| Dec 31, 2003 | 482.50M | -33.63% |
| Dec 31, 2002 | 727.00M | -34.83% |
| Dec 31, 2001 | 1.12B | 26.61% |
View and export this data all the way back to 2001. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.84B |
| Johnson & Johnson | 429.72B |
| AbbVie | 375.50B |
| UnitedHealth Group | 285.64B |
| AstraZeneca | 253.68B |
| Novartis AG | 252.55B |
| Novo Nordisk | 244.67B |
| Abbott Laboratories | 231.38B |